FILICE, GAETANO
 Distribuzione geografica
Continente #
NA - Nord America 5.716
AS - Asia 4.300
EU - Europa 3.166
SA - Sud America 483
Continente sconosciuto - Info sul continente non disponibili 162
AF - Africa 106
OC - Oceania 11
Totale 13.944
Nazione #
US - Stati Uniti d'America 5.607
CN - Cina 2.268
SG - Singapore 902
IE - Irlanda 762
UA - Ucraina 465
HK - Hong Kong 386
DE - Germania 378
VN - Vietnam 359
RU - Federazione Russa 346
BR - Brasile 335
FI - Finlandia 299
FR - Francia 220
SE - Svezia 199
IT - Italia 170
GB - Regno Unito 155
IN - India 84
CA - Canada 59
BD - Bangladesh 58
AR - Argentina 48
ZA - Sudafrica 46
IQ - Iraq 39
PL - Polonia 36
ES - Italia 32
MX - Messico 32
JP - Giappone 31
CO - Colombia 30
EC - Ecuador 26
BE - Belgio 23
NL - Olanda 22
ID - Indonesia 16
SA - Arabia Saudita 16
TR - Turchia 16
VE - Venezuela 15
PH - Filippine 14
MA - Marocco 12
AT - Austria 10
JO - Giordania 10
AE - Emirati Arabi Uniti 9
AU - Australia 9
LT - Lituania 9
MY - Malesia 9
KR - Corea 8
PE - Perù 8
PK - Pakistan 8
PT - Portogallo 8
TN - Tunisia 8
AZ - Azerbaigian 7
CL - Cile 7
ET - Etiopia 7
NP - Nepal 7
UZ - Uzbekistan 7
EG - Egitto 6
IL - Israele 6
IR - Iran 6
PY - Paraguay 6
CZ - Repubblica Ceca 5
DZ - Algeria 5
KZ - Kazakistan 5
AM - Armenia 4
EU - Europa 4
HN - Honduras 4
MD - Moldavia 4
UY - Uruguay 4
CH - Svizzera 3
KE - Kenya 3
LB - Libano 3
MU - Mauritius 3
RO - Romania 3
SN - Senegal 3
TH - Thailandia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BO - Bolivia 2
BY - Bielorussia 2
CG - Congo 2
CR - Costa Rica 2
DK - Danimarca 2
DM - Dominica 2
JM - Giamaica 2
KG - Kirghizistan 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
OM - Oman 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SR - Suriname 2
SV - El Salvador 2
TJ - Tagikistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
BZ - Belize 1
CI - Costa d'Avorio 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
GA - Gabon 1
Totale 13.766
Città #
Dublin 762
Chandler 740
San Jose 676
Jacksonville 563
Nanjing 497
Ashburn 466
Singapore 449
Hong Kong 377
Beijing 369
Dallas 315
Boardman 237
Nanchang 215
Princeton 178
Houston 162
Lawrence 155
Changsha 151
Shenyang 145
Ho Chi Minh City 138
Lauterbourg 137
Hebei 134
Medford 133
Wilmington 126
Los Angeles 117
Jiaxing 106
New York 95
Tianjin 91
Ann Arbor 87
Hangzhou 77
Hanoi 74
Helsinki 72
Munich 61
Buffalo 60
Shanghai 60
Council Bluffs 52
Moscow 52
Redondo Beach 51
Milan 44
Santa Clara 41
Johannesburg 36
São Paulo 33
Turku 30
Norwalk 29
Tokyo 29
Orem 28
Brooklyn 25
Falkenstein 25
Woodbridge 25
Frankfurt am Main 24
Chennai 23
Chicago 23
Verona 23
Montreal 21
Warsaw 21
Brussels 20
Baghdad 19
San Francisco 19
Phoenix 18
The Dalles 18
Des Moines 17
Denver 16
Fairfield 16
Seattle 16
Zhengzhou 16
Haiphong 15
Pavia 15
London 14
Quito 14
Da Nang 13
Rio de Janeiro 12
Toronto 12
Atlanta 11
Biên Hòa 11
Guangzhou 11
Kunming 11
Ningbo 11
Amsterdam 10
Brasília 10
Curitiba 10
Jinan 10
Mexico City 10
Nuremberg 10
Poplar 10
Washington 10
Amman 9
Columbus 9
Dhaka 9
Mumbai 9
Rome 9
Boston 8
Falls Church 8
Guayaquil 8
Jeddah 8
Manchester 8
Orange 8
Porto Alegre 8
Pune 8
Buenos Aires 7
Medellín 7
Redwood City 7
Stockholm 7
Totale 9.202
Nome #
Kinetics of p24 antigenemia, IgM, IgG antibodies to p24 and p41 and Ig virus isolation in rabbits experimentally infected with HIV-1 179
Aggressive daily interferon therapy in HIV-HCV coinfected patients 153
Distinct mutational drug resistance profiles of HIV-1 RNA in plasma in culture isolates of patients receiving antiretroviral theraphy 150
Booster PCR: evaluation of an improved method for amplification of a few HIV-1 proviral DNA sequences 146
Predictors of bacterial pneumonia in Evaluation of SUbcutaneous Interleukin-2 in a Randomized International Trial (ESPRIT). 142
Accuracy of ultrasound imaging technique for assessing lipoatrophy in HIV-infected subjects. 139
The Pavia consensus statement 135
In vitro sensitivity of 3 strains of Leptospira interrogans to 3 different antibiotics 131
Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study. 131
Detection of IgG anti-HIV antibodies in mice experimentally infected with HIV-1 129
Accuracy of real-time shear wave elastography for assessing liver fibrosis in chronic hepatitis C: a pilot study 128
Mice and rabbits: Animal models for HIV-1 infection 126
Effect of teicoplanin and vancomycin on Staphylococcus aureus ultrastructure 125
Host factors affecting the outcome of treatment of hepatitis C 124
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen. 124
[New trends in the therapy of cryptococcosis in AIDS patients] 122
Acute liver failure during lamivudine tratment in a hepatitis B cirrhotic patient 122
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection. 121
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction. 120
Chemotherapy of toxoplasmic encephalitis in AIDS patients 120
The association of "standard ELISA" and HIV (env) ELISA for detection and confirmation of HIV antibodies in human sera 119
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 119
IgM-IFA, IgM-ELISA, DS-IgM-ELISA, IgM-ISAGA, performed on whole serum and IgM fractions, for detection of IgM anti-toxoplasma antibodies during pregnancy 118
Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection. 118
A promising cultural-biomolecular method for rapid isolation and identification of mycobacteria 117
A New complement fixation test for toxoplasmosis. Comparison with other serological methods 114
An improved method for increasing the sensitivity of direct agglutination test (D.A.T.) to the detection of IgM and IgG anti-toxoplasma antibodies 111
Prevalence of HIV-1 inetgrase mutations related to resistance to dolutegravir in raltegravir naive and pretrated patients. 110
Endocytosis constitute the infectious route of HIV-1 entry in human and rabbit monocytes lacking the CD4 receptor 109
Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment 109
Life cycle of P. carinii in the lung of immuno-compromised hosts: an ultrastructural study. 109
Comparison between the complement fixation test LBCF-H100-TTE, IHAT and IgM-IFAT performed on pure IgM fractions in acute acquired and congenital toxoplasmosis 108
Daily Interferon therapy in HIV-HCV coinfected patients: Preliminary Report 108
A comparison of IHA and ELISA tests in the detection of antibodies to entamoeba histolytica 108
Comparison between IgM-IFA and DS-IgM-ELISA performed on IgM fractions and whole sera in acute acquired toxoplasmosis 107
Management of hepatitis C in human immunodeficiency virus-infected patients 105
A novel methodology for large-scale phylogeny partition 105
Transfusion-transmitted virus infection in HIV-1-seropositive patients 104
Controlled attenuation parameter for evaluating liver steatosis in chronic viral hepatitis. 104
General issues on microbial translocation in HIV-infected patients 103
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 103
Point shear wave elastography method for assessing liver stiffness. 102
Human immunodeficiency virus (HIV): an ultrastructural study 102
Specificity and sensitivity of 3rd generation EIA for detection of HCV antibodies among intravenous drug-users 102
[Protocols for the diagnostic verification of lymph node toxoplasmosis] 102
Hepatotoxicity and nelfinavir: a meta-analysis 101
Comments on the review 'Care of patients with hepatitis C and HIV co-infection' by Soriano et al. 101
Arterial stiffness evaluation in HIV-positive patients: a multicenter matched control study. 101
Overview on the incidence and the characteristics of HIV-related opportunistic infections and neoplasms of the heart: impact of highly active antiretroviral therapy 100
Hepatitis B virus co-infection in human immunodeficiency virus-infected subjects 99
Duration of immune protection after hepatitis B vaccine in newborns from HBsAg-positive carrier mothers 99
Rapid hepatitis B virus-DNA decay in co-infected HIV-hepatitis B virus 'eminus' patients with YMDD mutations after 4 weeks of tenofovir therapy 98
The morphogenesis of BLV (bovine leukemia virus) cultivated on FLK (fetal lamb kidney): an ultrastructural study 96
Management of hepatocellular carcinoma in human immunodeficiency virus-infected patients. 96
High prevalence of metabolic syndrome among HIV-infected patients: link with the cardiovascular risk 96
Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy 96
Hepatitis B immunization in infants of hepatitis B surface antigen-negative mothers 96
Detection of IgM anti-toxoplasma antibodies in acute acquired and congenital toxoplasmosis 95
Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV 95
Could Tenofovir - Modify the Model - End-Stage Liver - Disease (MELD) Score in Patients - With End-Stage Liver Disease Eligible for Liver Transplantation? 94
Impact of the M184V resistance mutation on virological efficacy and durability of lamivudine-based dual antiretroviral regimens as maintenance therapy in individuals with suppressed HIV-1 RNA: A cohort study 94
Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy 94
Minimal invasive Treatment for Hydatid Abdominal Cysts: PAIR (Puncture, Aspiration, Injection, Reaspiration)- State of the Art 93
Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV 93
Low rate of virological failure and maintenance of susceptibility to HIV-1 protease inhibitors with first-line lopinavir/ritonavir-based antiretroviral treatment in clinical practice. 93
Practice guidelines for the treatment of hepatitis C: Recommendations from an AISF/SIMIT/SIMAST expert opinion meeting 92
Comparison of ELISA and indirect immunofluorescence in the detection of IgG and IgM antitoxoplasma antibodies 92
A comparative ultrastructural study of the low virulent strain PV-C1/81 and RH strain cultured in A9, Vero, SIRC cell lines 92
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1 positive patients after commencement of a new highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER COHORT 91
Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides 89
Malattie Infettive 88
Malattie Infettive 88
Prevalence and histologic features of transfusion transmitted virus and hepatitis C virus coinfection in a group of HIV patients. 88
Forecast model for the evaluation of economic resources employed in the health care of patients with HIV infection. 88
Fungaemia in hospitalized patients 88
Rate of CD4+ cell count increase over periods of viral load suppressione: relationship with the number of previous virological failures. 87
Efficacy of a short-term amphotericin B + flucytosine combination therapy followed by itraconazole monotherapy in acute and chronic AIDS-associated cryptococcosis 87
Detection of antibodies to p24 and gp41 epitopes of HIV by ELISA using the recombinant core protein (p24) and envelope synthetic protein (gp41). 87
Entamoebiasi e parassitosi intestinali in un centro di ricovero psichiatrico.Valutazione di efficacia di protocolli di trattamento chemioprofilattico-chemioterapeutico 86
Quantification of HIV-1 proviral DNA in patients with undetectable plasma viremia over long-term highly active antiretroviral therapy 86
HIV type 1 intraperitoneal infection of rabbits permits early detection of serum antibodies to Gag, Pol, and Env proteins, neutralizing antibodies, and proviral DNA from peripheral blood mononuclear cells 86
Recenti Acquisizioni in tema di Diagnosi,terapia e Prevenzione delle Epatiti Acute ad Etiologia Virale. 85
Pathogenesis of liver damage in HCV-HIV patients 85
Transverse myelitis associated with Mycoplasma pneumoniae pneumonitis: a report of two cases 85
Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naïve and pretreated patients 85
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis. 83
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005) 83
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. 83
Behavioral correlates of adherence to antiretroviral therapy 83
Manuale di Virologia Clinica 82
Natural history of chronic hepatitis B in co-infected patients. 82
Evolution of transmitted HIV-1 drug resistance in HIV-1 infected patients in Italy from 2000 to 2010. 82
Prevalence of metabolic syndrome among HIV patients 82
Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients 82
Epatiti Virali Acute 80
Natural history of compensated viral cirrhosis in a cohort of patients with HIV infection. 79
Tuberculosis meningitis in adults: 5 cases 79
Pathogenesis of liver damage in HCV-HIV patients. 79
Quantitative assessment of cell-associated and cell-free virus in cervicovaginal samples of HIV-1-infected women 79
Correlation between FIB4, liver stiffness and metabolic parameters in patients with HIV and hepatitis C virus co-infection. 79
Totale 10.285
Categoria #
all - tutte 60.961
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.961


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022647 0 5 6 3 12 10 17 42 31 5 112 404
2022/20232.120 244 152 16 173 220 217 0 116 893 9 44 36
2023/2024641 63 126 29 38 72 166 12 54 8 17 17 39
2024/20251.774 38 180 35 60 18 69 67 124 447 40 200 496
2025/20264.656 333 337 513 499 544 182 919 151 394 395 222 167
2026/2027126 87 39 0 0 0 0 0 0 0 0 0 0
Totale 13.944